¡GoConqr estrena diseño! Cuéntanos qué te parece.

Test

pathoanatomy mcq-s 251-350

timi Lamikanra 100 preguntas 5,0 (2 valoraciones)

Hacer el test

Preguntas del test (100)

  1. 1select the epithelial ovarian tumours
    1. Agranulosa cell tumor
    2. Bthecoma
    3. Cbrenner's tumor
    4. Dandroblastoma
  2. 2252: which of the following are epithelial ovarian tumors
    1. Athecoma
    2. Bserous granuloma
    3. Cdysgerminoma
    4. Dbrenner's tumor
  3. 3253: which of the following are sex-ord stromal ovarian tumors
    1. Agranulosa cell tumor
    2. Bthecoma
    3. Cdysgerminoma
    4. Dandroblastoma
  4. 4254: which of the following ovarian tumors are benign
    1. Apapillary cystadenoma
    2. Bpapillary cystadenocarcinoma
    3. Cdysgerminoma
    4. Dthecoma
  5. 5255: which of the following ovarian tumors are malignant
    1. Aserous cystadenoma
    2. Bendodermal yolk sac tumor
    3. Cthecoma
    4. Dmucinous cystadenocarcinoma
  6. 6256: in fibro-cystic breast disease we find the following
    1. Asolitary nodule
    2. Bmultiple nodules
    3. Ccyst
    4. Dpapillary proliferations
  7. 7257: in fibroadenoma of the breast we find
    1. Amultiple nodules
    2. Bcysts
    3. Csolitary nodules
    4. Dproliferated mammary ducts and stroma
  8. 8258: benign prostate hyperplaia is seen most commonly in
    1. Amedian lobe
    2. BSubscapular prostate tissuee
    3. Clateral lobes
    4. Dperiurethreal prostate tissue
  9. 9259: prostate carcinoma is usualy seen in
    1. Alateral lobe
    2. Bpossterior lobe
    3. Cperiuretheral prostatic tissue
    4. Dsubcapsular prostate tissue
  10. 10260: which two markers are valuable for the diagnosis of prostate cancer
    1. APSA
    2. BHER2
    3. CPAP
    4. Destrogen receptors

Información

Descripción
Test sobre pathoanatomy mcq-s 251-350, creado por timi Lamikanra el 17/01/2018.
Idioma
English
Visitas
538
Valoración
5,0 de 5 · 2 valoraciones
Valora este test
Valora este test

Escríbenos

¿Sobre qué es tu mensaje?

¿Qué te parece el nuevo diseño?

¿Te gusta?